Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
OA04.03 A Randomized Phase 3 Study of Camrelizumab plus Chemotherapy as 1st Line Therapy for Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer
PaperCitations, authors & open-access status
OA04.03 A Randomized Phase 3 Study of Camrelizumab plus Chemotherapy as 1st Line Therapy for Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 23 citations, 2019 year and bronze oa status.
23
Citations
2019
Year
bronze
OA Status